American Diabetes Association issues new guidance, “Hemoglobin A1C Targets for Glycemic Control with Pharmacologic Therapy for Nonpregnant Adults with Type 2 Diabetes Mellitus” Read more
Soin Neuroscience secures IRB approval to commence clinical case series studying spinal cord stimulator alogrithms Read more
Biohaven enrolls first patient in Phase 3 Clinical Trial to assess Rimegepant Zydis ODT to treat Migraine Read more
Lyric finishes enrollment in Phase 2 PRROMOTE Study of LP101 in Enteral Feeding Intolerance Read more
Aimmune Therapeutics declares results of Phase 3 PALISADE Trial of AR101 for peanut allergy patients Read more